Impaktované onkogyn publikace 2010-2013

S IMPAKT FAKTOREM

2013

p16INK4a Immunoprofiles of Squamous Lesions of the Uterine Cervix-Implications for the Reclassification of Atypical Immature Squamous Metaplasia.

Skapa P, Robova H, Rob L, Zamecnik J.

Pathol Oncol Res. 2013 May 18.

 

Current status of sentinel lymph node mapping in the management of endometrial cancer.

Robova H, Rob L, Halaska MJ, Pluta M, Skapa P.

Expert Rev Anticancer Ther. 2013 Jan;13(1):55-61.

 

High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer.

Robova H, Rob L, Halaska MJ, Pluta M, Skapa P, Strnad P, Lisy J, Komar M.

Gynecol Oncol. 2013 Jan;128(1):49-53.

 

Han SN, Kesic VI, Van Calsteren K, Petkovic S, Amant F; Skrzypczyk A, Hasenburg A, Uzan C, Roussy G, Lok C, Benedicic C, Vaitkiene D, Peccatori F, Markowska J, Dahl-Steffensen K, Iraki M, Halaska M, Fumagalli M, Ottevanger N, Pavlidis N, Reed N, Cottier O, Zola P, Panici PB, Kimmig R, Fruscio R, Rouzier R, Loibl S, Lang U, Kolawa W.

Cancer in pregnancy: a survey of current clinical practice.

Eur J Obstet Gynecol Reprod Biol, 2013;167(1):18-23.                                 IF 1,974

 

Robova H, Rob L, Halaska MJ, Pluta M, Skapa P.

Current status of sentinel lymph node mapping in the management of endometrial cancer.

Expert Rev Anticancer Ther. 2013, 13(1):55-61.                                            IF 2,652

 

Manchanda,R, Godfrey,M, Wong-Taylor,LA, Halaska,MJ, Burnell,M, Grabowski,J, Gultekin,M, Haidopoulos, D, Zapardiel,I, Vranes,B, Kesic,V, Zola,P, Colombo,N, Verheijen,R, Bossart,M, Piek,J

The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO)

Annals Oncol, 2013, 24/4:944-952                                                                IF 6,425

 

 

2012

 

Novackova, M, Halaska, MJ., Robova,H.,Mala,I., Chmel, R., Pluta, M., Rob, L.

A Prospective Study in Detection of Lower Limb Lymphoedema and Evaluation of Quality of Life after Vulvar Cancer Surgery.

Int J Gynecol Cancer, 2012, in press                                       IF 2,179

 

Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H, Heyns L, Han SN, Tomek V, Mertens L, Ottevanger PB.

Long term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.

Lancet Oncol, 2012 Mar;13(3):256-64.                                 IF 17.76

 

 

2011   

 

Rob L, Škapa P, Robová H: Fertility- sparing surgery in patiens with cervical cancer

The Lancet Oncol 2011; 12, 192-200

(ISSN 1470-2045)                                                                IF 17.764

 

Fučíková J, Králíková P, Fialová A,  Brtnický T, Rob L, Bartůňková J, Špíšek R: Human tumor cells killed  by anthracyclines induce a tumor-specific immune response.

Cancer  Research 2011; 71(14):1-13

(ISSN 0008-5472)                                                                IF 8.234

 

Tachezy R, Šmahelová J, Saláková M,  Arbyn M, Rob L, Skapa P, Jirásek P, Hamříková E:

Human papillomavirus genotype distribution  in Czech women and men with deseases etiologically linked to HPV.

Plos  One 2011 July 13                                                          IF 4.411

 

Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, Piek JM, Manchanda R, Grimm C, Dallaku K, Babloyan S, Moisei A, Van Gorp T, Cadron I, Markov P, Micevska A, Halaska M, Steffensen KD, Gristsenko L, Nissi R, Lambaudie E, Tsitsishvili Z, Haidopoulos D, Dimitrios T, Novak Z, Peiretti M, Dunenova G, Macuks R, Hetland TE, Michelsen TM, Martins FC, Achimas-Cadariu P, Ulrikh EA, Uharcek P, Malic S, Ognjenovic D, Zapardiel I, Johann S, Sukhin VS, Manchanda R.

Gynecologic Oncology Training Systems in Europe. A Report From the European Network of Young Gynaecological Oncologists

Int J Gynecol Cancer, 2011;21(8):1500-1506                     IF 1.471

 

Cibula D, Abu-Rustum NR, Dusek L, Zikán M, Zaal A, Sevcik L, Kenter GG,
Querleu D, Jach R, Bats AS, Dyduch G, Graf P, Klat J, Lacheta J, Meijer CJ, Mery
E, Verheijen R, Zweemer RP. Prognostic significance of low volume sentinel lymph
node disease in early-stage cervical cancer. Gynecol Oncol. 2011 Nov 25. 

 

Cibula D, Querleu D, Morrow CP. Terminology and classification system of
radical hysterectomy. Gynecol Oncol. 2012 Jan;124(1):174-5.
Lorkova L, Pospisilova J, Lacheta J, Leahomschi S, Zivny J, Cibula D, Zivny J,
Petrak J. Decreased concentrations of retinol-binding protein 4 in sera of
epithelial ovarian cancer patients: a potential biomarker identified by
proteomics. Oncol Rep. 2012 Feb;27(2):318-24. doi: 10.3892/or.2011.1513. 

 

Verheijen RH, Cibula D, Zola P, Reed N; on behalf of council of the European
Society of Gynaecologic Oncology. Cancer Antigen 125: Lost to Follow-Up?: A
European Society of Gynaecological Oncology Consensus Statement. Int J Gynecol
Cancer. 2012 Jan;22(1):170-174.
Cibula D, Zikan M, Dusek L, Majek O. Oral contraceptives and risk of ovarian
and breast cancers in BRCA mutation carriers: a meta-analysis. Expert Rev
Anticancer Ther. 2011 Aug;11(8):1197-207. 

 

Cibula D, Verheijen R, Lopes A, Dusek L; ESGO Council. Current clinical
practice in cytoreductive surgery for advanced ovarian cancer: a European survey.
Int J Gynecol Cancer. 2011 Oct;21(7):1219-24. 

 

Slama J, Freitag P, Dundr P, Duskova J, Fischerova D, Zikan M, Pinkavova I,
Cibula D. Outcomes of pregnant patients with Pap smears classified as atypical
glandular cells. Cytopathology. 2011 Aug 17. doi:10.1111/j.1365-2303.2011.00898.x.
Zikan M, Fischerova D, Pinkavova I, Dundr P, Cibula D. Ultrasonographic
appearance of metastatic non-gynecological pelvic tumors. Ultrasound Obstet
Gynecol. 2011 Aug 15. doi: 10.1002/uog.10068.
Cibula D, Verheijen R, Lopes A, Amant F, Beller U, Colombo N, Gitsch G, Kesic
V, Kimmig R, Markowska J, Marth C, Reed N, Rodolakis A, Salvesen H, Vaitkiene D,
van der Zee AG, Zola P. Training in bowel and upper abdominal surgery in
gynaecological oncology: European Society of Gynecological Oncology (ESGO)
Statement. Int J Gynecol Cancer. 2011 Oct;21(7):1264-5.
Cibula D, Abu-Rustum NR, Benedetti-Panici P, Köhler C, Raspagliesi F, Querleu
D, Morrow CP.

New classification system of radical hysterectomy: emphasis on a
three-dimensional anatomic template for parametrial resection. Gynecol Oncol.
2011 Aug;122(2):264-8.

 

Dundr P, Fischerová D, Povýšil C, Tvrdík D, Cibula D. Primary Synovial
Sarcoma of the Uterus. Pathol Oncol Res. 2011 Apr 14. 

 

Cibula D, Pinkavova I, Dusek L, Slama J, Zikan M, Fischerova D, Freitag P,
Dundr P. Local control after tailored surgical treatment of early cervical
cancer. Int J Gynecol Cancer. 2011 May;21(4):690-8.

 

Cibula D, Widschwendter M, Zikan M, Dusek L. Underlying mechanisms of ovarian
cancer risk reduction after tubal ligation. Acta Obstet Gynecol Scand. 2011
Jun;90(6):559-63. doi: 10.1111/j.1600-0412.2011.01114.x.�
Harter P, Sehouli J, Reuss A, Hasenburg A, Scambia G, Cibula D, Mahner S,
Vergote I, Reinthaller A, Burges A, Hanker L, Pölcher M, Kurzeder C, Canzler U,
Petry KU, Obermair A, Petru E, Schmalfeldt B, Lorusso D, du Bois A. Prospective
validation study of a predictive score for operability of recurrent ovarian
cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO
Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. Int J Gynecol
Cancer. 2011 Feb;21(2):289-95.
Cibula D, Widschwendter M, Májek O, Dusek L. Tubal ligation and the risk of
ovarian cancer: review and meta-analysis. Hum Reprod Update. 2011
Jan-Feb;17(1):55-67. 

 

Epstein E, Van Holsbeke C, Mascilini F, Måsbäck A, Kannisto P, Ameye L, Fischerova D, Zannoni G, Vellone V, Timmerman D, Testa AC. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size. Ultrasound Obstet Gynecol. 2011 Nov;38(5):586-93.
Fischerova D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol. 2011 Sep;38(3):246-66.
Guerriero S, Testa AC, Timmerman D, Van Holsbeke C, Ajossa S, Fischerova D, Franchi D, Leone FP, Domali E, Alcazar JL, Parodo G, Mascilini F, Virgilio B, Demidov VN, Lipatenkova J, Valentin L. Imaging of gynecological disease (6): clinical and ultrasound characteristics of ovarian dysgerminoma. Ultrasound Obstet Gynecol. 2011 May;37(5):596-602. doi: 10.1002/uog.8958.
Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni  AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol. 2011 Oct;38(4):456-65. doi: 10.1002/uog.9030.
Van Calster B, Valentin L, Van Holsbeke C, Zhang J, Jurkovic D, Lissoni AA, Testa AC, Czekierdowski A, Fischerová D, Domali E, Van de Putte G, Vergote I, Van Huffel S, Bourne T, Timmerman D. A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2420-8.

 

 

2010

 

Rob L. Halaška M, Robová H: Nerve-sparing and individually tailored surgery for cervical cancer

The Lancet Oncol 2010; 11: 292-301

(ISSN 1470-2045)                                                                IF 17.764

 

Rob L, Pluta M, Robová H: Less radical surgery than radical hysterectomy in early stage cervical cancer

Gynecol Oncol 2010; 117(1): 148

(ISSN 0090-8258)                                                                IF 3.760

 

Rob L, Pluta M, Škapa P,  Robová H: Advanced in fertility-sparing surgery for cervical cancer

Expert Rev anticancer Ther 2010;10(7): 1101-1114  

(ISSN 1473-7140)                                                                IF 2.976

 

Kotaška K, Urinovská R, Klapálková E, Průša R, Rob L, Binder T: Re-evalution of cord blood arterial and venous reference ranges for pH, pO2, pCO2, according to spontaneous or cesarean delivery

J Clin Lab Anal 2010; 24(5): 300-304

(ISSN 0877-8013)                                                                IF 1.031

 

Robová H, Halaska M, Pluta M, Skapa P, Strnad P, Lisý J, Rob L: The role of neoadjuvant  chemotherapy and surgery in cervical cancer

Int J Gynecol Cancer 2010; 20, Suppl.2: 42-46

(ISSN 1048-891X)                                                                IF 1.558

 

Halaška MJ, Nováčková M, Malá I,  Pluta M, Chmel R, Stankušová H, Robová H, Rob L:
A prospective study of postoperative lymphedema after surgery for cervical cancer

Int J Gynecol Cancer 2010; 20(5): 900-904

(ISSN 1048-891X)                                                                IF 1.558

 

Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L, Mir O, Neven P, Ottevanger N, Pans S, Peccatori F, Rouzier R, Senn H, Struikmans H, Christiaens M, Cameron D, Du Bois A

Breast cancer in pregnancy: recommendations of an international consensus meeting

Eur J Cancer, 2010;46(18):3158-68                                       IF 4,121 

 

Van Calsteren,K, Verbesselt,R, Ottevanger,N, Halaska,M, Heyns,L, Van Bree,R, de Bruijn,E, Chai,D, Delforge,M, Noens,L, Renard,R, Witteveen,E, Rob,L, de Hoon,J, Amant,F
Pharmacokinetics of Chemotherapeutic Agents in Pregnancy: a Preclinical and Clinical Study
Acta Obstet Gynecol Scand, 2010 Oct;89(10):1338-1345     IF 1,618

 

Van Calsteren,K., Heyns,L., De Smet,F., Van Eycken,L., Gziri,MM., Van Gemert,W., Halaska,M., Vergote,I., Ottenvanger,N., Amant,F.

Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.

J Clin Oncol, 2010;28(4):683-9.                                             IF 17,157

 

Amant,F., Brepoels,L., Halaska,MJ, Gziri,MM., Calsteren,KV.

Gynaecologic cancer complicating pregnancy: An overview.

Best Pract Res Clin Obstet Gynaecol, 2010;24(1):61-79        IF 1,867

 

Slama J, Drazdakova M, Dundr P, Fischerova D, Zikan M, Pinkavova I, Freitag P, Fanta M, Kuzel D, Zima T, Cibula D. High-risk human papillomavirus DNA in paraaortic lymph nodes in advanced stages of cervical carcinoma. J Clin Virol. 2010 Oct 27.
Slama J, Fischerova D, Pinkavova I, Zikan M, Cibula D. Human papillomavirus DNA presence in pelvic lymph nodes in cervical cancer. Int J Gynecol Cancer. 2010 Jan;20(1):126-32.

 

Antoniou, AC; Beesley, J; McGuffog, L; Sinilnikova, OM; Healey, S; Neuhausen, SL; Ding, YC; Rebbeck, TR; Weitzel, JN; Lynch, HT; Isaacs, C; Ganz, PA; Tomlinson, G; Olopade, OI; Couch, FJ; Wang, XS; Lindor, NM; Pankratz, VS; Radice, P; Manoukian, S; Peissel, B; Zaffaroni, D; Barile, M; Viel, A; Allavena, A; Dall\’Olio, V; Peterlongo, P; Szabo, CI; Zikán, M , et al. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction. Cancer Research, 2010, 70, 23, s. 9742-9754.

 

Cibula D. Response to: Late morbidity following nerve-sparing radical hysterectomy. Gynecologic Oncology, 2010, 119, 1, s. 169-170.�

Cibula D, Abu-Rustum NR. Classification system for pelvic lymphadenectomy in cervical cancer. Gynecologic oncology, 2010, 118, 1, s. 94-95.�

Cibula D, Abu-Rustum NR. Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system. Gynecologic oncology, 2010, 116, 1, s. 33-37.
Cibula D, Gompel A, Mueck AO, LaVechia C, Hannaford PC, Skouby SO, Zikán M, Dušek L. Hormonal contraception and risk of cancer. Journal für Reproduktionsmedizin und Endokrinologie, 2010, 7, 1, s. 39-55.�

Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, Zikán M, Dusek L. Hormonal contraception and risk of cancer. Human reproduction update, 2010, 16, 6, s. 631-650.�

Cibula, David; Sláma, Jiří; Velechovská, Petra; Fischerová, Daniela; Zikán, Michal; Pinkavová, Ivana; Hill, M. Factors Affecting Spontaneous Voiding Recovery After Radical Hysterectomy. International Journal of Gynecological Cancer, 2010, 20, 4, s. 685-690.

Cibula, David; Velechovská, Petra; Sláma, Jiří; Fischerová, Daniela; Pinkavová, Ivana; Pavlišta, David; Dundr, Pavel; Hill, M; Freitag, Pavel; Zikán, Michal. Late morbidity following nerve-sparing radical hysterectomy. Gynecologic Oncology, 2010, 116, 3, s. 506-511.�

Dundr, Pavel; Fischerová, Daniela; Povýšil, Ctibor; Berková, Adéla; Bauerová, Lenka; Cibula, David. Uterine Tumors with Neuroectodermal Differentiation. A Report of 4 Cases. Pathology and Oncology Research, 2010, 16, 4, s. 601-608.
Matějů, Martin; Stříbrná, Jana; Zikán, Michal; Kleibl, Zdeněk; Janatová, Markéta; Kormunda, Stanislav; Novotný, Jan; Souček, Pavel; Petruželka, Luboš; Pohlreich, Petr. Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers. Neoplasma, 2010, 57, 3, s. 280-285.
Tichá, Ivana; Kleibl, Zdeněk; Stříbrná, Jana; Kotlas, Jaroslav; Zimovjanová, Martina; Matějů, Martin; Zikán, Michal; Pohlreich, Petr. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Research and Treatment, 2010, 124, 2, s. 337-347.

Timmerman, D; Ameye, L; Fischerová, Daniela; Epstein, E , et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. British Medical Journal, 2010, 341, c6839, s. 1-8.�

Timmerman, D; Van Calster, B; Testa, AC; Guerriero, S; Fischerová, Daniela; Lissoni, AA; Van Holsbeke, C , et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound in Obstetrics and Gynecology, 2010, 36, 2, s. 226-234.
Van Holsbeke, C.; Van Belle, V.; Leone, FP.; Guerriero, S.; Paladoni, D.; Melis, GB.; Greggi, S.; Fischerová, Daniela , et al. Prospective external validation of the ‚ovarian crescent sign‘ as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology. Ultrasound in Obstetrics and Gynecology, 2010, 36, 1, s. 81-87.�

Van Holsbeke, C.; Van Calster, B.; Guerriero , S.; Savelli, L; Paladini, D.; Lissoni , AA.; Czekierdowski, A.; Fischerová, Daniela , et al. Endometriomas: their ultrasound characteristics. Ultrasound in Obstetrics and Gynecology, 2010, 35, 6, s. 730-740.
Vrzáčková, Petra; Weiss, Petr; Cibula, David. Sexual morbidity following radical hysterectomy for cervical cancer. Expert review of anticancer therapy, 2010, 10, 7, s. 1037-1042. 

Wang, XS; Pankratz, VS; Fredericksen, Z; Tarrell, R; Karaus, M; McGuffog, L; Pharaoh, PD; Ponder, BA; Dunning, AM; Peock, S; Cook, M; Oliver, C; Frost, D; Sinilnikova, OM; Stoppa-Lyonnet, D; Mazoyer, S; Houdayer, C; Hogervorst, FBL; Hooning, MJ; Ligtenberg, MJ; Spurdle, A; Chenevix-Trench, G; Schmutzler, RK; Wappenschmidt, B; Engel, C; Meindl, A; Domchek, SM; Nathanson, KL; Rebbeck, TR; Singer, CF; Gschwantler-Kaulich, D; Dressler, C; Fink, A; Szabo, CI; Zikán, Michal , et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics, 2010, 19, 14, s. 2886-2897.�

Zikán, Michal; Fischerová, Daniela; Pinkavová, Ivana; Dundr, Pavel; Cibula, David. Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology. Ultrasound in Obstetrics and Gynecology, 2010, 36, 6, s. 767-772.